Cargando…
A Response to: Letter to the Editor Regarding [Esophageal Dysfunction and Systemic Sclerosis: Drugs Should be Kept in Mind]
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314522/ https://www.ncbi.nlm.nih.gov/pubmed/35716237 http://dx.doi.org/10.1007/s40744-022-00458-5 |
| _version_ | 1784754336671203328 |
|---|---|
| author | Li, Bo Yan, Junqing Pu, Jincheng Tang, Jianping Xu, Shuchang Wang, Xuan |
| author_facet | Li, Bo Yan, Junqing Pu, Jincheng Tang, Jianping Xu, Shuchang Wang, Xuan |
| author_sort | Li, Bo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9314522 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93145222022-07-27 A Response to: Letter to the Editor Regarding [Esophageal Dysfunction and Systemic Sclerosis: Drugs Should be Kept in Mind] Li, Bo Yan, Junqing Pu, Jincheng Tang, Jianping Xu, Shuchang Wang, Xuan Rheumatol Ther Letter Springer Healthcare 2022-06-18 /pmc/articles/PMC9314522/ /pubmed/35716237 http://dx.doi.org/10.1007/s40744-022-00458-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Letter Li, Bo Yan, Junqing Pu, Jincheng Tang, Jianping Xu, Shuchang Wang, Xuan A Response to: Letter to the Editor Regarding [Esophageal Dysfunction and Systemic Sclerosis: Drugs Should be Kept in Mind] |
| title | A Response to: Letter to the Editor Regarding [Esophageal Dysfunction and Systemic Sclerosis: Drugs Should be Kept in Mind] |
| title_full | A Response to: Letter to the Editor Regarding [Esophageal Dysfunction and Systemic Sclerosis: Drugs Should be Kept in Mind] |
| title_fullStr | A Response to: Letter to the Editor Regarding [Esophageal Dysfunction and Systemic Sclerosis: Drugs Should be Kept in Mind] |
| title_full_unstemmed | A Response to: Letter to the Editor Regarding [Esophageal Dysfunction and Systemic Sclerosis: Drugs Should be Kept in Mind] |
| title_short | A Response to: Letter to the Editor Regarding [Esophageal Dysfunction and Systemic Sclerosis: Drugs Should be Kept in Mind] |
| title_sort | response to: letter to the editor regarding [esophageal dysfunction and systemic sclerosis: drugs should be kept in mind] |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314522/ https://www.ncbi.nlm.nih.gov/pubmed/35716237 http://dx.doi.org/10.1007/s40744-022-00458-5 |
| work_keys_str_mv | AT libo aresponsetolettertotheeditorregardingesophagealdysfunctionandsystemicsclerosisdrugsshouldbekeptinmind AT yanjunqing aresponsetolettertotheeditorregardingesophagealdysfunctionandsystemicsclerosisdrugsshouldbekeptinmind AT pujincheng aresponsetolettertotheeditorregardingesophagealdysfunctionandsystemicsclerosisdrugsshouldbekeptinmind AT tangjianping aresponsetolettertotheeditorregardingesophagealdysfunctionandsystemicsclerosisdrugsshouldbekeptinmind AT xushuchang aresponsetolettertotheeditorregardingesophagealdysfunctionandsystemicsclerosisdrugsshouldbekeptinmind AT wangxuan aresponsetolettertotheeditorregardingesophagealdysfunctionandsystemicsclerosisdrugsshouldbekeptinmind AT libo responsetolettertotheeditorregardingesophagealdysfunctionandsystemicsclerosisdrugsshouldbekeptinmind AT yanjunqing responsetolettertotheeditorregardingesophagealdysfunctionandsystemicsclerosisdrugsshouldbekeptinmind AT pujincheng responsetolettertotheeditorregardingesophagealdysfunctionandsystemicsclerosisdrugsshouldbekeptinmind AT tangjianping responsetolettertotheeditorregardingesophagealdysfunctionandsystemicsclerosisdrugsshouldbekeptinmind AT xushuchang responsetolettertotheeditorregardingesophagealdysfunctionandsystemicsclerosisdrugsshouldbekeptinmind AT wangxuan responsetolettertotheeditorregardingesophagealdysfunctionandsystemicsclerosisdrugsshouldbekeptinmind |